Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | FERMT1 |
| Upstream (Parents) |
|---|
| (<<) ACTG1 → FERMT1 |
| (<<) ASNS → FERMT1 |
| (<<) B3GNT3 → FERMT1 |
| (<<) CD3EAP → FERMT1 |
| (<<) DDR1 → FERMT1 |
| (<<) FUT4 → FERMT1 |
| (<<) HDAC2 → FERMT1 |
| (<<) ITGA2 → FERMT1 |
| (<<) MTHFD2 → FERMT1 |
| (<<) MYC → FERMT1 |
| (<<) PHLDA2 → FERMT1 |
| (<<) RPIA → FERMT1 |
| (<<) YWHAB → FERMT1 |
| Downstream (Children) |
|---|
| FERMT1 → ADORA2B (>>) |
| FERMT1 → ATP10B (>>) |
| FERMT1 → CXCL3 (>>) |
| FERMT1 → EPHB3 (>>) |
| FERMT1 → KCNN4 (>>) |
| FERMT1 → KIAA1199 (>>) |
| FERMT1 → MST1R (>>) |
| FERMT1 → NDOR1 (>>) |
| FERMT1 → NXT1 (>>) |
| FERMT1 → PLCB4 (>>) |
| FERMT1 → PRKAB1 (>>) |
| FERMT1 → PYGB (>>) |
| FERMT1 → SFN (>>) |
| FERMT1 → SLMO2 (>>) |
| FERMT1 → TMC7 (>>) |
| FERMT1 → TRIB3 (>>) |
